Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study Meeting Abstract
| Authors: | Reckamp, K. L.; Akerley, W.; Calvo, E.; Clarke, J.; Edelman, M. J.; He, K.; Moreno, V.; Neal, J. W.; Owonikoko, T. K.; Patel, J. D.; Patel, S. P.; Riess, J. W.; Sacher, A. G.; Turcotte, S.; Villaruz, L. C.; Zauderer, M. G.; Farsaci, B.; Skoura, N.; Chisamore, M.; Johnson, M. L. |
| Abstract Title: | Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz260.112 |
| Language: | English |
| ACCESSION: | WOS:000491295504252 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz260.112 |
| Notes: | Meeting Abstract: 1590TiP -- Appears on pages v657-v658 of the abstract book -- Source: Wos |
